Cutaneous malignant melanoma

Deborah L. Cummins, Jordan M. Cummins, Hardin Pantle, Michael A. Silverman, Aimee L. Leonard, Arjun Chanmugam

Research output: Contribution to journalReview article


Skin cancer has become the most common neoplasm in the United States. With early diagnosis and appropriate management, most skin cancers have an overall 5-year survival rate of 95%. Cutaneous malignant melanoma (CMM), however, has a significantly higher morbidity and mortality, resulting in 65% of all skin cancer deaths. Although the long-term survival rate for patients with metastatic melanoma is only 5%, early detection of CMM carries an excellent prognosis, with surgical excision often being curative. Primary care physicians can play a critical role in reducing morbidity and mortality from CMM by recognizing patients at risk, encouraging the adoption of risk-reducing behaviors, and becoming adept at identifying suspicious lesions.

Original languageEnglish (US)
Pages (from-to)500-507
Number of pages8
JournalMayo Clinic proceedings
Issue number4
StatePublished - Apr 2006


ASJC Scopus subject areas

  • Medicine(all)

Cite this

Cummins, D. L., Cummins, J. M., Pantle, H., Silverman, M. A., Leonard, A. L., & Chanmugam, A. (2006). Cutaneous malignant melanoma. Mayo Clinic proceedings, 81(4), 500-507.